Hypertrophic cardiomyopathy (HCM ... reviews the various forms of HCM and describes the currently available treatment modalities for obstructive HCM. Further research will be necessary to ...

Trametinib, a mitogen-activated protein kinase (MEK) inhibitor, reduces mortality and morbidity in children with severe hypertrophic cardiomyopathy (HCM) caused by pathogenic variants in the RAS ...

Dr. Wang spoke to MedPage Today to discuss the diagnosis of apical HCM, and distinct features of this disease subtype. In order to effectively manage patients with hypertrophic cardiomyopathy (HCM ...

Trametinib, a mitogen-activated protein kinase (MEK) inhibitor, reduces mortality and morbidity in children with severe hypertrophic cardiomyopathy (HCM) caused by pathogenic variants in the RAS ...

Hypertrophic cardiomyopathy, apical variant. Still-frame, long-axis cardiac magnetic resonance stack of images (steady-state free-precession; diastole) through the left ventricle demonstrating ...

A recent study published in The Lancet highlighted the potential of AI-driven cardiac imaging to identify under-diagnosed ...